Fundraising Fox
/Companies
Sign in

Abionic

Founded 2010 · 30 employees on LinkedIn · 4 known investors

Find your way into Abionic

Each arrow is one introduction. Sign up to fill in the first one.

237 people can intro you to Nicolas

Ask Nicoletta Casanova to introduce you to Nicolas Durand

You →Nicoletta · together at Swiss Medtech →Nicolas

68 people can intro you to Iwan

Ask Jamie Chen to introduce you to Iwan Märki

You →Jamie · together at EPFL →Iwan

Sign up to find every way you can get introduced to Abionic

  • Your email: who you already know at Abionic, and who your contacts know
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Abionic team
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Sign up with GoogleAlready have an account? Log in

Abionic develops the abioSCOPE, a near-patient rapid diagnostic platform that uses nanofluidic immunoassay technology to deliver lab-quality results from a single drop of blood within minutes. The platform is designed for clinical settings including hospitals and laboratories to enable early detection of conditions such as sepsis.

BiotechDeep TechDigital HealthHealthtechMedical Devices

Founders & leadership

Abionic was founded in 2010 by Iwan Märki and Nicolas Durand.

IM
Iwan MärkiCTO and co-founderCTO and co-founder of Abionic, which develops the abioSCOPE, a near-patient rapid diagnostic platform using nanofluidic immunoassay technology to deliver results from a single drop of blood. His expertise spans biomedical optics, high-resolution microscopy, fluorescence spectroscopy, micro- and nano-optical technologies, photonic crystals, interferometry, and robotics.
NDNicolas Durand
Nicolas DurandFounderNicolas Durand founded Abionic in 2010, serving as CEO until February 2024; the company is an EPFL spin-off that developed abioSCOPE, a rapid diagnostic platform using nanofluidic immunoassay technology. He subsequently became CEO of Fondation Campus Biotech Geneva, a research center supported by EPFL, the University of Geneva, and other Geneva-based institutions.

Investors · 4

BlueOcean VenturesreportedGeneva · $270K – $1.4M

How we know: funding news · Not right? Tell us

Also in the syndicate · 2

InvestiereZürcher Kantonal bank

Funding

SEC filings, press & company announcements
  • Undisclosed amountSeries CMar 2018

    Investiere, Zürcher Kantonal bank

    Source ↗

Source: company announcements and press reports — follow each round's link for the claim.

In the news

Abionic Successfully Raises CHF20 Million in Series C Financing - BioSpacebiospace.com · Mar 2018

Frequently asked questions

What does Abionic do?
Abionic develops the abioSCOPE, a near-patient rapid diagnostic platform that uses nanofluidic immunoassay technology to deliver lab-quality results from a single drop of blood within minutes. The platform is designed for clinical settings including hospitals and laboratories to enable early detection of conditions such as sepsis.
Who founded Abionic?
Abionic was founded by Iwan Märki, Nicolas Durand in 2010.
Who are Abionic's investors?
Abionic's investors include Polytech Ecosystem Ventures, BlueOcean Ventures.